Amyloid PET: A Questionable Single Primary Surrogate Efficacy Measure on Alzheimer’s Disease Immunotherapy Trials

Manuscript Number: 

22-0841R1

Author(s): 
Abass Alavi, Jorge R. Barrio, Poul F. Høilund-Carlsen, Mona-Elisabeth Revheim, Nagichettiar Satyamurthy

Disclosures

Abass Alavi

  • Nothing to Disclose

Jorge R. Barrio

  • Nothing to Disclose

Poul F. Høilund-Carlsen

  • Nothing to Disclose

Mona-Elisabeth Revheim

  • Nothing to Disclose

Nagichettiar Satyamurthy

  • Nothing to Disclose